Aura Biosciences, Inc. (AURA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tr

Frazier Life Sciences Management L.P. grew its position in shares of Aura Biosciences, Inc. (NASDAQ:

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage b

BlackRock Inc. bought a new stake in shares of Aura Biosciences, Inc. (NASDAQ: AURA) in the second q

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) (“Aura” or the “Com

ADAR1 Capital Management LLC bought a new position in shares of Aura Biosciences, Inc. (NASDAQ: AURA

Aura Biosciences, Inc. is focused on late-stage development of Bel-sar for early choroidal melanoma,

HC Wainwright & Co. analyst Andres Y. Maldonado maintains Aura Biosciences (NASDAQ:AURA) with

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which missed the analy

US stock futures higher, Deckers Outdoor shares fall after reporting Q1 results. Other stocks also d

SAP SE (NYSE: SAP) reported Q2 earnings of $1.85 per share, missing the consensus estimate. Revenue

BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage bi

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Auranova Resources Inc. (TSXV: AURA)

Topline data for the 15-month primary endpoint are anticipated in the second half of 2027."Compl

Enrollment of 108 patients completed in the registration-enabling Phase 3 CoMpass trial Topline data

Aura Biosciences NASDAQ: AURA is shifting its focus toward regulatory preparation and commercializat

Aura Biosciences NASDAQ: AURA executives outlined the company's strategy for its lead candidate bel-

BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) (“Aura” or the “Compa

BOSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage bio

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.50) per share which missed the analy

Phase 3 CoMpass trial advancing toward enrollment completion, supporting 2H 2027 topline data Natali

Amsterdam, 6 May 2026 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTE

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-

Global Business Travel Group Inc (GBTG), a NYSE-listed company, saw its stock rise 57% on Monday af

Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company develo

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-

US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 resu

Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company develo

Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision th

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. ("Aura") (Nasdaq: AURA), a clinical-

HC Wainwright & Co. analyst Andrew S. Fein maintains Aura Biosciences (NASDAQ:AURA) with a Bu

U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-

Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the pu

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market tradin

  On Tuesday, 647 companies set new 52-week lows.

  On Wednesday, 220 stocks hit new 52-week lows.

  During Tuesday, 95 stocks hit new 52-week lows.

Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Mond